Prevalence of bruxism in children receiving treatment for attention deficit hyperactivity disorder: A pilot study

Journal of Clinical Pediatric Dentistry

Volumn 29, Issue 1, 2004, Pages 63-67

  Malki, Ghadah A ^a   Zawawi, Khalid H ^b   Melis, Marcello ^c   Hughes, Christopher V ^b  

^a KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^b BOSTON UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPRAZOLAM; AMFEBUTAMONE; AMPHETAMINE DERIVATIVE; BUSPIRONE; CENTRAL STIMULANT AGENT; CLOMIPRAMINE; CLONIDINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GUANFACINE; HALOPERIDOL; LITHIUM; METHYLPHENIDATE; NORTRIPTYLINE; PSYCHOSTIMULANT AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VALPROIC ACID;

ARTICLE; ATTENTION DEFICIT DISORDER; BRUXISM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CHOICE; DRUG INDICATION; DRUG SAFETY; FEMALE; FREQUENCY ANALYSIS; HUMAN; MALE; PILOT STUDY; PREVALENCE; QUESTIONNAIRE; SCHOOL CHILD; SYMPTOMATOLOGY;

EID: 8844237017     PISSN: 10534628     EISSN: None     Source Type: Journal    
DOI: 10.17796/jcpd.29.1.3j86338656m83522     Document Type: Article

References (34)

1. Diagnostic and statistical manual of mental disorders: DSM-IV Washington, D.C.: American Psychiatric Publishing, Incorporated; 1994. (First MBa, Pincus HA, eds. Diagnostic and Statistical Manual of Men).
2. Taylor EA, et al. Hyperkinetic disorders: prevalence, definition and association. In: Eric A. Taylor, et al. eds. The epidemiology of childhood hyperactivity. Oxford, England: Oxford university Press, 93-113, 1991.
3. Baumgaertel A, Wolraich ML, Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 34: 629-38, 1995.
4. Owens JA, Maxim R, Nobile C, McGuinn M, Msall M. Parental and self-report of sleep in children with attention- deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 154: 549-55, 2000.
5. Anders TF, Eiben LA. Pediatric sleep disorders: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36: 9-20, 1997.
6. Corkum P, Moldofsky H, Hogg-Johnson S, Humphries T, Tannock R. Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication. J Am Acad Child Adolesc Psychiatry 38: 1285-93, 1999.
7. Pliszka SR. The use of psychostimulants in the pediatric patient. Pediatr Clin North Am 45: 1085-98, 1998.
8. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35: 409-32, 1996.
9. Gillberg C, Melander H, von Knorring AL, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 54: 857-64, 1997.
10. Attanasio R. An overview of bruxism and its management. Dent Clin North Am. 41: 229-41, 1997.
11. Okeson JP. Orofacial Pain: Guidelines for assessment, diagnosis and management Chicago, Quintessence Publishing, 1996.
12. Thorpy MJ. Diagnostic classification steering committee. In: Association ASD, ed. The International Classification of Sleep Disorders: Diagnostic & Coding Manual. Rochester, MN, Allen Press, 1990.
13. Seligman DA, Pullinger AG, Solberg WK. The prevalence of dental attrition and its association with factors of age, gender, occlusion, and TMJ symptomatology. J Dent Res 67: 1323-33, 1988.
14. Melis M, Abou-Atme YS. Prevalence of bruxism awareness in a Sardinian population. Cranio 21: 144-51, 2003.
15. Glaros AG, Rao SM. Bruxism: a critical review. Psychol Bull 84: 767-81, 1977.
16. Okeson JP. Etiology of functional disturbances in the masticatory system. In: Okeson JP, ed. Management of temporomandibular disorders and occlusion. 4th ed. St. Louis: Mosby Year Book, pp. 149-179, 1998.
17. Pierce CJ, Chrisman K, Bennett ME, Close JM. Stress, anticipatory stress, and psychologic measures related to sleep bruxism. J Orofac Pain 9: 51-6, 1995.
18. Goulet JP, Lund JP, Montplaisir JY, Lavigne GJ. Daily clenching, nocturnal bruxism and stress and their association with TMD symptoms [abstract]. J Orofac Pain 75: 120, 1993.
19. Westrup DA, Keller SR, Nellis TA, Hicks RA. Arousability and bruxism in male and female college students. Percept Mot Skills 75(3 Pt 1): 796-8, 1992.
20. Hicks RA, Conti P. Nocturnal bruxism and self reports of stress-related symptoms. Percept Mot Skills 72(3 Pt 2): 1182, 1991.
21. Rugh JD, and Solberg WK. Psychological implications in temporomandibular pain and dysfunction. In: Zarb GA, and Carlsson GE, eds. Temporomandibular joint function and dysfunction. Copenhagen: Munksgaard, p. 255, 1979.
22. Faulkner KD. Bruxism: a review of the literature. Part I [see comments]. Aust Dent J 35: 266-76, 1990.
23. Cannistraci AJ, Friedrich JA. A multidimensional approach to bruxism and TMD. N Y State Dent J 53: 31-4, 1987.
24. Rugh JD, Ohrbach R. Occlusal parafunction. In: Mohl ND, Zarb GA, Carlsson GE, and Rugh JD, eds. A textbook of occlusion. 3rd ed. Chicago, Quintessence, 249-261, 1991.
25. Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med 333: 944, 1995.
26. Ellsworth AJ, Witt DM, Dugdale DC, Oliver LM. Mosby's medical drug reference. St. Louis, Mosby, 1999.
27. Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr 130: 670-4, 1997.
28. Castellanos FX, Giedd JN, Elia J, et al. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36: 589-96, 1997.
29. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 52: 444-55, 1995.
30. Gadow KD, Nolan E, Sprafkin J, Sverd J. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. J Dev Behav Pediatr 16: 167-76, 1995.
31. Lobbezoo F, van Denderen RJ, Verheij JG, Naeije M. Reports of SSRI-Associated Bruxism in the Family Physician's Office. J Orofac Pain 15: 340-346, 2001.
32. Fitzgerald K, Healy D. Dystonias and dyskinesias of the jaw associated with the use of SSRis. Hum Psychopharmacol 10: 215-219, 1995.
33. Amir I, Hermesh H, Gavish A. Bruxism secondary to antipsychotic drug exposure: a positive response to propranolol. Clin Neuropharmacol 20: 86-9, 1997.
34. Gara L, Roberts W. Adverse response to methylphenidate in combination with valproic acid. J Child Adolesc Psychopharmacol 10: 39-43, 2000.